Testosterone Replacement Therapy and the Risk of Hypoglycemia

We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control. When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Analía Verónica, Costanzo, Pablo René, Peuchot, Verónica Andrea, Knoblovits, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885825/
https://www.ncbi.nlm.nih.gov/pubmed/31827946
http://dx.doi.org/10.1155/2019/9616125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885825/
https://www.ncbi.nlm.nih.gov/pubmed/31827946
http://dx.doi.org/10.1155/2019/9616125

Ejemplares similares